News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Van Naarden Jacob
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
4
| Van Naarden Jacob (EVP and CEO Loxo@Lilly) has filed a Form 4 on ELI LILLY & Co|
Txns:
| Granted 2,407 shares
@ $345.12, valued at
$830.7k
|
|
| 02/17/2022 |
4
| Van Naarden Jacob (SVP, CEO LoxoONC, Pres LlyONC) has filed a Form 4 on ELI LILLY & Co|
Txns:
| Paid exercise price by delivering 2,186 shares
@ $243.84, valued at
$533k
Exercised 5,461 restricted stock units
@ $0 |
|
| 12/30/2021 |
4
| Van Naarden Jacob (SVP, CEO LoxoONC, Pres LlyONC) has filed a Form 4 on ELI LILLY & Co|
Txns:
| Granted 3,618 restricted stock units
@ $0 |
|
| 09/07/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/15/2019 |
4
| Van Naarden Jacob (COO) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Disposed/sold 19,000 shares
@ $235, valued at
$4.5M
Disposed/sold 35,026 options to buy
@ $3.648, valued at
$127.8k
Disposed/sold 78,943 options to buy
@ $13.67, valued at
$1.1M
Disposed/sold 43,000 options to buy
@ $31.69, valued at
$1.4M
Disposed/sold 74,000 options to buy
@ $26.27, valued at
$1.9M
Disposed/sold 35,000 options to buy
@ $43.56, valued at
$1.5M
Disposed/sold 200,000 options to buy
@ $84.88, valued at
$17M
Disposed/sold 57,000 options to buy
@ $139.77, valued at
$8M
|
|
| 01/17/2019 |
4/A
| Van Naarden Jacob (COO) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Exercised 1,541 shares
@ $3.648, valued at
$5.6k
|
|
| 01/02/2019 |
4
| Van Naarden Jacob (COO) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Granted 57,000 options to buy
@ $139.77, valued at
$8M
|
|
| 12/12/2018 |
4
| Van Naarden Jacob (Chief Business Officer) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 400 shares
@ $130.59, valued at
$52.2k
Sold 1,000 shares
@ $132.23, valued at
$132.2k
Sold 900 shares
@ $133.17, valued at
$119.9k
Sold 1,400 shares
@ $134.65, valued at
$188.5k
Sold 500 shares
@ $135.14, valued at
$67.6k
Sold 200 shares
@ $136.48, valued at
$27.3k
Sold 100 shares
@ $137.39, valued at
$13.7k
Sold 400 shares
@ $134.74, valued at
$53.9k
Sold 800 shares
@ $135.92, valued at
$108.7k
Sold 1,759 shares
@ $137.09, valued at
$241.1k
Sold 500 shares
@ $137.73, valued at
$68.9k
|
|
| 11/28/2018 |
4
| Van Naarden Jacob (Chief Business Officer) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 1,556 shares
@ $151.71, valued at
$236.1k
Sold 1,644 shares
@ $152.49, valued at
$250.7k
Sold 1,500 shares
@ $154, valued at
$231k
Sold 600 shares
@ $155.3, valued at
$93.2k
Sold 200 shares
@ $156.45, valued at
$31.3k
Sold 949 shares
@ $138.08, valued at
$131k
Sold 1,170 shares
@ $138.83, valued at
$162.4k
Sold 300 shares
@ $140.13, valued at
$42k
Sold 500 shares
@ $141.69, valued at
$70.8k
Sold 500 shares
@ $143.08, valued at
$71.5k
Sold 200 shares
@ $143.92, valued at
$28.8k
|
|
| 10/05/2018 |
4
| Van Naarden Jacob (Chief Business Officer) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 2,000 shares
@ $165.1303, valued at
$330.3k
Sold 400 shares
@ $165.885, valued at
$66.4k
Sold 500 shares
@ $167.192, valued at
$83.6k
Sold 2,300 shares
@ $168.8465, valued at
$388.3k
Sold 300 shares
@ $169.4, valued at
$50.8k
Exercised 4,500 shares
@ $3.648, valued at
$16.4k
Sold 600 shares
@ $160.6217, valued at
$96.4k
Sold 1,100 shares
@ $161.5205, valued at
$177.7k
Sold 1,194 shares
@ $162.701, valued at
$194.3k
Sold 1,006 shares
@ $163.7845, valued at
$164.8k
Sold 600 shares
@ $164.6767, valued at
$98.8k
|
|
| 09/14/2018 |
4
| Van Naarden Jacob (Chief Business Officer) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 756 shares
@ $164.4383, valued at
$124.3k
Sold 1,885 shares
@ $165.3156, valued at
$311.6k
Sold 1,059 shares
@ $166.738, valued at
$176.6k
Sold 1,000 shares
@ $167.392, valued at
$167.4k
Sold 200 shares
@ $168.785, valued at
$33.8k
Sold 600 shares
@ $171.0267, valued at
$102.6k
Sold 2,700 shares
@ $165.4463, valued at
$446.7k
Sold 1,500 shares
@ $166.6347, valued at
$250k
Sold 300 shares
@ $167.4867, valued at
$50.2k
Exercised 5,500 options to buy
@ $3.648, valued at
$20.1k
Exercised 4,500 options to buy
@ $3.648, valued at
$16.4k
|
|
| 08/15/2018 |
4
| Van Naarden Jacob (Chief Business Officer) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 730 shares
@ $157.6155, valued at
$115.1k
Sold 3,070 shares
@ $158.6619, valued at
$487.1k
Sold 1,500 shares
@ $159.6893, valued at
$239.5k
Sold 200 shares
@ $160.595, valued at
$32.1k
Sold 600 shares
@ $159.082, valued at
$95.4k
Sold 3,199 shares
@ $159.907, valued at
$511.5k
Sold 701 shares
@ $160.6997, valued at
$112.7k
Exercised 5,500 options to buy
@ $3.648, valued at
$20.1k
Exercised 4,500 options to buy
@ $3.648, valued at
$16.4k
|
|
| 07/11/2018 |
4
| Van Naarden Jacob (Chief Business Officer) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 300 shares
@ $185.3402, valued at
$55.6k
Sold 200 shares
@ $186.19, valued at
$37.2k
Sold 641 shares
@ $187.3749, valued at
$120.1k
Sold 200 shares
@ $188.04, valued at
$37.6k
Sold 100 shares
@ $189.12, valued at
$18.9k
Sold 100 shares
@ $191.64, valued at
$19.2k
Sold 680 shares
@ $178.3943, valued at
$121.3k
Sold 361 shares
@ $179.5006, valued at
$64.8k
Sold 300 shares
@ $180.9467, valued at
$54.3k
Sold 100 shares
@ $181.96, valued at
$18.2k
Sold 100 shares
@ $183.19, valued at
$18.3k
|
|
| 06/21/2018 |
4
| Van Naarden Jacob (Chief Business Officer) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 865 shares
@ $176.4413, valued at
$152.6k
Sold 576 shares
@ $177.4674, valued at
$102.2k
Sold 100 shares
@ $178.23, valued at
$17.8k
Sold 1,141 shares
@ $179.0001, valued at
$204.2k
Sold 200 shares
@ $179.755, valued at
$36k
Sold 200 shares
@ $180.9, valued at
$36.2k
Exercised 1,541 options to buy
@ $3.648, valued at
$5.6k
Exercised 12,000 options to buy
@ $3.648, valued at
$43.8k
Exercised 1,541 options to buy
@ $3.648, valued at
$5.6k
|
|
| 05/16/2018 |
4
| Van Naarden Jacob (Chief Business Officer) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 241 shares
@ $134.2496, valued at
$32.4k
Sold 600 shares
@ $137.4958, valued at
$82.5k
Sold 691 shares
@ $138.7007, valued at
$95.8k
Sold 9 shares
@ $139.45, valued at
$1.3k
Sold 200 shares
@ $133.35, valued at
$26.7k
Sold 300 shares
@ $135.78, valued at
$40.7k
Sold 841 shares
@ $138.3518, valued at
$116.4k
Sold 200 shares
@ $139.04, valued at
$27.8k
Exercised 1,541 options to buy
@ $3.648, valued at
$5.6k
Exercised 1,541 options to buy
@ $3.648, valued at
$5.6k
|
|
| 04/26/2018 |
4
| Van Naarden Jacob (Chief Business Officer) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 241 shares
@ $129.581, valued at
$31.2k
Sold 300 shares
@ $130.6167, valued at
$39.2k
Sold 500 shares
@ $131.882, valued at
$65.9k
Sold 500 shares
@ $133.086, valued at
$66.5k
Sold 300 shares
@ $128.7167, valued at
$38.6k
Sold 100 shares
@ $129.45, valued at
$12.9k
Sold 600 shares
@ $130.935, valued at
$78.6k
Sold 541 shares
@ $132.0546, valued at
$71.4k
Exercised 1,541 options to buy
@ $3.648, valued at
$5.6k
Exercised 1,541 options to buy
@ $3.648, valued at
$5.6k
|
|
| 03/15/2018 |
4
| Van Naarden Jacob (Chief Business Officer) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 100 shares
@ $128.85, valued at
$12.9k
Sold 500 shares
@ $130.28, valued at
$65.1k
Sold 400 shares
@ $131.405, valued at
$52.6k
Sold 441 shares
@ $132.4784, valued at
$58.4k
Sold 100 shares
@ $134.05, valued at
$13.4k
Sold 895 shares
@ $131.054, valued at
$117.3k
Sold 646 shares
@ $132.0227, valued at
$85.3k
Exercised 1,541 options to buy
@ $3.648, valued at
$5.6k
Exercised 1,541 options to buy
@ $3.648, valued at
$5.6k
|
|
| 02/14/2018 |
4
| Van Naarden Jacob (Chief Business Officer) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 500 shares
@ $92.21, valued at
$46.1k
Sold 741 shares
@ $93.8254, valued at
$69.5k
Sold 300 shares
@ $94.4933, valued at
$28.3k
Sold 300 shares
@ $94.33, valued at
$28.3k
Sold 100 shares
@ $96.6, valued at
$9.7k
Sold 100 shares
@ $97.87, valued at
$9.8k
Sold 1,041 shares
@ $101.0455, valued at
$105.2k
Exercised 1,541 options to buy
@ $3.648, valued at
$5.6k
Exercised 1,541 options to buy
@ $3.648, valued at
$5.6k
|
|
| 01/18/2018 |
4
| Van Naarden Jacob (Chief Business Officer) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 641 shares
@ $86.5316, valued at
$55.5k
Sold 200 shares
@ $87.095, valued at
$17.4k
Sold 100 shares
@ $88.36, valued at
$8.8k
Sold 500 shares
@ $90.07, valued at
$45k
Sold 100 shares
@ $90.45, valued at
$9k
Sold 446 shares
@ $86.2953, valued at
$38.5k
Sold 200 shares
@ $87.96, valued at
$17.6k
Sold 695 shares
@ $89.2259, valued at
$62k
Sold 200 shares
@ $89.865, valued at
$18k
Exercised 1,541 options to buy
@ $3.648, valued at
$5.6k
Exercised 1,541 options to buy
@ $3.648, valued at
$5.6k
|
|
| 01/05/2018 |
4
| Van Naarden Jacob (Chief Business Officer) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Granted 200,000 options to buy
@ $84.88, valued at
$17M
|
|
| 12/18/2017 |
4
| Van Naarden Jacob (Chief Business Officer) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 841 shares
@ $82.6527, valued at
$69.5k
Sold 700 shares
@ $84.0114, valued at
$58.8k
Sold 400 shares
@ $77.6025, valued at
$31k
Sold 600 shares
@ $78.7183, valued at
$47.2k
Sold 241 shares
@ $79.6906, valued at
$19.2k
Sold 200 shares
@ $80.79, valued at
$16.2k
Sold 100 shares
@ $82.86, valued at
$8.3k
Exercised 1,541 options to buy
@ $3.648, valued at
$5.6k
Exercised 1,541 options to buy
@ $3.648, valued at
$5.6k
|
|
| 11/29/2017 |
4
| Van Naarden Jacob (Chief Business Officer) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 841 shares
@ $74.0811, valued at
$62.3k
Sold 400 shares
@ $74.9625, valued at
$30k
Sold 300 shares
@ $76.7633, valued at
$23k
Sold 600 shares
@ $73.2683, valued at
$44k
Sold 500 shares
@ $74.034, valued at
$37k
Sold 441 shares
@ $75.5187, valued at
$33.3k
Exercised 1,541 options to buy
@ $3.648, valued at
$5.6k
Exercised 1,541 options to buy
@ $3.648, valued at
$5.6k
|
|
| 11/01/2017 |
4
| Van Naarden Jacob (Chief Business Officer) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 1,100 shares
@ $86.8718, valued at
$95.6k
Sold 241 shares
@ $87.7796, valued at
$21.2k
Sold 200 shares
@ $88.77, valued at
$17.8k
Sold 1,141 shares
@ $86.3655, valued at
$98.5k
Sold 400 shares
@ $86.945, valued at
$34.8k
Exercised 1,541 options to buy
@ $3.648, valued at
$5.6k
Exercised 1,541 options to buy
@ $3.648, valued at
$5.6k
|
|
| 09/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2017 |
4
| Van Naarden Jacob (Chief Business Officer) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Sold 1,000 shares
@ $73.545, valued at
$73.5k
Sold 541 shares
@ $74.074, valued at
$40.1k
Sold 1,541 shares
@ $73.4158, valued at
$113.1k
Exercised 1,541 options to buy
@ $3.648, valued at
$5.6k
Exercised 1,541 options to buy
@ $3.648, valued at
$5.6k
|
|
| 03/17/2017 |
4
| Van Naarden Jacob (Chief Business Officer) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Granted 35,000 options to buy
@ $43.56, valued at
$1.5M
|
|
| 12/08/2016 |
4
| Van Naarden Jacob (Chief Business Officer) has filed a Form 4 on Loxo Oncology, Inc.|
Txns:
| Granted 74,000 options to buy
@ $26.27, valued at
$1.9M
|
|
| 03/08/2016 |
3
| Van Naarden Jacob (Chief Business Officer) has filed a Form 3 on Loxo Oncology, Inc. |
|
|